The Diagnostic Importance of Anti-Mullerian Hormone in Predicting Polycystic Ovary Syndrome among Women of Reproductive Age

Jishamol K, Gargi R Nair, Navami S

Abstract: According to research, the most prevalent endocrinopathy among women in reproductive age is polycystic ovary syndrome (PCOS). Up to one-fifth of women of reproductive age are affected by PCOS, which results in an ovulatory subfertility. Anti-Mullerian hormone (AMH) levels greater than 3.8 to 5 ng/mL have been suggested by some research as a diagnostic threshold for PCOS. The purpose of this study is to evaluate the diagnostic importance of AMH levels in predicting PCOS among women of reproductive age.

Keywords: Polycystic ovarysyndrome, Anti-Mullerian hormone, Rotterdam Criteria, Endocrinopathy, Hyperandrogenism

How to Cite?: Jishamol K, Gargi R Nair, Navami S, "The Diagnostic Importance of Anti-Mullerian Hormone in Predicting Polycystic Ovary Syndrome among Women of Reproductive Age", Volume 11 Issue 12, December 2022, International Journal of Science and Research (IJSR), Pages: 122-123, https://www.ijsr.net/getabstract.php?paperid=SR221130221737, DOI: https://dx.doi.org/10.21275/SR221130221737